Subbarao Venkata Yalla, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urodynamics | 49 | 2012 | 347 | 2.610 |
Why?
|
| Urinary Bladder | 52 | 2012 | 1172 | 2.020 |
Why?
|
| Urethra | 37 | 2015 | 408 | 1.890 |
Why?
|
| Urinary Bladder, Neurogenic | 18 | 2015 | 165 | 1.340 |
Why?
|
| Urinary Bladder Neck Obstruction | 18 | 2012 | 81 | 1.330 |
Why?
|
| Muscle, Smooth | 26 | 2012 | 934 | 1.200 |
Why?
|
| Urinary Incontinence | 15 | 2015 | 496 | 1.050 |
Why?
|
| Prostatic Hyperplasia | 12 | 2013 | 523 | 0.980 |
Why?
|
| Urination | 20 | 2000 | 204 | 0.950 |
Why?
|
| Muscle Contraction | 22 | 2012 | 1240 | 0.870 |
Why?
|
| Urination Disorders | 11 | 2002 | 241 | 0.860 |
Why?
|
| Urinary Catheterization | 13 | 2015 | 202 | 0.850 |
Why?
|
| Urinary Retention | 3 | 2015 | 111 | 0.710 |
Why?
|
| Spinal Cord Injuries | 16 | 2008 | 931 | 0.640 |
Why?
|
| Urinary Bladder, Overactive | 4 | 2012 | 106 | 0.620 |
Why?
|
| Urinary Incontinence, Stress | 6 | 2003 | 183 | 0.540 |
Why?
|
| Clitoris | 1 | 2015 | 33 | 0.540 |
Why?
|
| Prostatic Diseases | 4 | 2000 | 56 | 0.520 |
Why?
|
| Coitus | 1 | 2015 | 133 | 0.510 |
Why?
|
| Prostatism | 1 | 2013 | 14 | 0.450 |
Why?
|
| Electrosurgery | 1 | 2013 | 58 | 0.440 |
Why?
|
| Pressure | 28 | 2007 | 1203 | 0.430 |
Why?
|
| Caveolins | 1 | 2012 | 104 | 0.420 |
Why?
|
| Transurethral Resection of Prostate | 1 | 2013 | 83 | 0.420 |
Why?
|
| Lasers, Solid-State | 1 | 2013 | 169 | 0.380 |
Why?
|
| Self Care | 1 | 2015 | 786 | 0.350 |
Why?
|
| Urinary Tract Infections | 5 | 2008 | 788 | 0.340 |
Why?
|
| Prostatectomy | 5 | 2003 | 1890 | 0.330 |
Why?
|
| Vaccinium macrocarpon | 1 | 2008 | 12 | 0.330 |
Why?
|
| Urine | 5 | 2008 | 370 | 0.280 |
Why?
|
| Caveolae | 3 | 2012 | 57 | 0.280 |
Why?
|
| Prostate | 4 | 2006 | 1774 | 0.260 |
Why?
|
| Urinary Bladder Diseases | 5 | 1997 | 166 | 0.250 |
Why?
|
| Plant Extracts | 1 | 2008 | 471 | 0.250 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 2002 | 0.240 |
Why?
|
| Penis | 6 | 2009 | 216 | 0.210 |
Why?
|
| Manometry | 2 | 2002 | 445 | 0.200 |
Why?
|
| Urinary Tract Physiological Phenomena | 2 | 1996 | 11 | 0.200 |
Why?
|
| Urethral Obstruction | 4 | 1998 | 56 | 0.200 |
Why?
|
| Isometric Contraction | 3 | 1996 | 143 | 0.190 |
Why?
|
| Urology | 6 | 2011 | 399 | 0.180 |
Why?
|
| Urethral Diseases | 5 | 1988 | 53 | 0.170 |
Why?
|
| Male | 97 | 2015 | 350118 | 0.170 |
Why?
|
| Sensory Thresholds | 1 | 2000 | 391 | 0.160 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2003 | 604 | 0.160 |
Why?
|
| DNA | 1 | 2012 | 7301 | 0.160 |
Why?
|
| Penile Diseases | 1 | 1998 | 46 | 0.160 |
Why?
|
| Aged | 57 | 2015 | 163280 | 0.150 |
Why?
|
| Ischemia | 4 | 2011 | 1907 | 0.150 |
Why?
|
| Abscess | 1 | 2000 | 607 | 0.140 |
Why?
|
| Bezoars | 1 | 1996 | 30 | 0.140 |
Why?
|
| Carcinoma, Transitional Cell | 1 | 2003 | 808 | 0.130 |
Why?
|
| Caveolin 1 | 3 | 2012 | 263 | 0.130 |
Why?
|
| Syncope | 1 | 1998 | 429 | 0.130 |
Why?
|
| Endocarditis, Bacterial | 1 | 2000 | 455 | 0.130 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2011 | 687 | 0.130 |
Why?
|
| Oxidative Stress | 4 | 2011 | 3086 | 0.130 |
Why?
|
| Dogs | 11 | 1999 | 3912 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 12072 | 0.120 |
Why?
|
| Nerve Degeneration | 2 | 2009 | 748 | 0.120 |
Why?
|
| Candidiasis | 1 | 1996 | 366 | 0.110 |
Why?
|
| Rheology | 5 | 1998 | 345 | 0.110 |
Why?
|
| Receptors, Purinergic | 1 | 2012 | 66 | 0.100 |
Why?
|
| Cystoscopy | 3 | 2003 | 134 | 0.100 |
Why?
|
| Urologic Diseases | 3 | 1998 | 244 | 0.100 |
Why?
|
| Middle Aged | 43 | 2015 | 213383 | 0.100 |
Why?
|
| Humans | 93 | 2015 | 744343 | 0.100 |
Why?
|
| Aged, 80 and over | 22 | 2015 | 57776 | 0.100 |
Why?
|
| Physical Therapy Modalities | 1 | 2015 | 550 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 1400 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2003 | 2245 | 0.090 |
Why?
|
| Reflex | 4 | 1986 | 365 | 0.090 |
Why?
|
| Angiotensin II | 3 | 2007 | 881 | 0.090 |
Why?
|
| Impotence, Vasculogenic | 1 | 2009 | 11 | 0.090 |
Why?
|
| Urethral Stricture | 3 | 1996 | 51 | 0.090 |
Why?
|
| Urinary Tract | 3 | 2011 | 309 | 0.090 |
Why?
|
| Muscles | 4 | 1979 | 1614 | 0.080 |
Why?
|
| Elasticity | 6 | 1991 | 657 | 0.080 |
Why?
|
| Proanthocyanidins | 1 | 2008 | 20 | 0.080 |
Why?
|
| Diagnostic Errors | 1 | 1996 | 1257 | 0.080 |
Why?
|
| Nursing Homes | 1 | 1996 | 1036 | 0.080 |
Why?
|
| Spinal Cord Diseases | 1 | 1991 | 298 | 0.080 |
Why?
|
| Coronary Artery Bypass | 1 | 1998 | 2289 | 0.080 |
Why?
|
| Catheters, Indwelling | 4 | 2003 | 426 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2003 | 4034 | 0.080 |
Why?
|
| Compliance | 4 | 2007 | 104 | 0.070 |
Why?
|
| Aging | 6 | 2012 | 8664 | 0.070 |
Why?
|
| Societies, Medical | 2 | 1996 | 3743 | 0.070 |
Why?
|
| Microscopy, Electron | 8 | 2007 | 2645 | 0.070 |
Why?
|
| Ultrasound, High-Intensity Focused, Transrectal | 1 | 2006 | 6 | 0.070 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 1970 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2012 | 8301 | 0.070 |
Why?
|
| Nerve Fibers | 1 | 2010 | 687 | 0.070 |
Why?
|
| Digital Rectal Examination | 1 | 2006 | 42 | 0.070 |
Why?
|
| Urothelium | 1 | 2008 | 277 | 0.070 |
Why?
|
| Cystitis | 2 | 1996 | 93 | 0.060 |
Why?
|
| Models, Biological | 6 | 2004 | 9583 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2008 | 2557 | 0.060 |
Why?
|
| Animals | 23 | 2015 | 168757 | 0.060 |
Why?
|
| Adult | 33 | 2008 | 214055 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2012 | 5179 | 0.060 |
Why?
|
| Prostheses and Implants | 3 | 2000 | 1387 | 0.060 |
Why?
|
| Trauma Severity Indices | 1 | 2006 | 481 | 0.060 |
Why?
|
| Ataxia | 1 | 2006 | 304 | 0.060 |
Why?
|
| Placebos | 1 | 2008 | 1676 | 0.060 |
Why?
|
| Prospective Studies | 12 | 2015 | 53288 | 0.060 |
Why?
|
| Rats | 4 | 2012 | 24260 | 0.060 |
Why?
|
| Female | 41 | 2015 | 380194 | 0.060 |
Why?
|
| Ureteral Obstruction | 3 | 1993 | 296 | 0.050 |
Why?
|
| Methods | 6 | 1980 | 1129 | 0.050 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 2029 | 0.050 |
Why?
|
| Data Collection | 2 | 2006 | 3341 | 0.050 |
Why?
|
| Single-Blind Method | 1 | 2006 | 1590 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2015 | 8324 | 0.050 |
Why?
|
| Diagnosis, Differential | 5 | 2000 | 12959 | 0.050 |
Why?
|
| Electric Stimulation | 6 | 2003 | 1767 | 0.050 |
Why?
|
| Ureter | 2 | 2003 | 375 | 0.050 |
Why?
|
| Atrophy | 1 | 2006 | 1583 | 0.050 |
Why?
|
| Rabbits | 5 | 2010 | 4894 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2002 | 19905 | 0.050 |
Why?
|
| Organ Size | 1 | 2006 | 2252 | 0.050 |
Why?
|
| Treatment Outcome | 4 | 2015 | 63114 | 0.050 |
Why?
|
| Motor Neurons | 5 | 1988 | 844 | 0.050 |
Why?
|
| Glomerular Filtration Rate | 1 | 2008 | 2170 | 0.050 |
Why?
|
| Mitochondria | 2 | 2011 | 3520 | 0.050 |
Why?
|
| Caveolin 3 | 2 | 2012 | 25 | 0.050 |
Why?
|
| Caveolin 2 | 2 | 2012 | 25 | 0.050 |
Why?
|
| Ultrasonography | 2 | 2006 | 5985 | 0.050 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2000 | 149 | 0.040 |
Why?
|
| Pelvis | 1 | 1984 | 730 | 0.040 |
Why?
|
| Electromyography | 6 | 1990 | 1379 | 0.040 |
Why?
|
| Silicones | 1 | 2000 | 250 | 0.040 |
Why?
|
| Oxygen | 1 | 2011 | 4189 | 0.040 |
Why?
|
| Sensitivity and Specificity | 4 | 2000 | 14722 | 0.040 |
Why?
|
| Gels | 1 | 2000 | 427 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 3 | 1996 | 1681 | 0.040 |
Why?
|
| Predictive Value of Tests | 3 | 2003 | 15076 | 0.040 |
Why?
|
| Microscopy, Electron, Transmission | 2 | 2011 | 712 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2003 | 759 | 0.040 |
Why?
|
| Pelvic Neoplasms | 2 | 1984 | 254 | 0.040 |
Why?
|
| Abdomen | 1 | 2004 | 1118 | 0.040 |
Why?
|
| Viscosity | 2 | 2004 | 328 | 0.040 |
Why?
|
| Kidney Calculi | 2 | 1979 | 465 | 0.040 |
Why?
|
| Regression Analysis | 2 | 1998 | 6459 | 0.040 |
Why?
|
| Kidney | 2 | 2012 | 7186 | 0.030 |
Why?
|
| Rupture, Spontaneous | 2 | 1996 | 354 | 0.030 |
Why?
|
| Models, Structural | 1 | 1996 | 361 | 0.030 |
Why?
|
| Diuresis | 1 | 1996 | 116 | 0.030 |
Why?
|
| Spasm | 1 | 1976 | 121 | 0.030 |
Why?
|
| Prostate-Specific Antigen | 1 | 2006 | 2494 | 0.030 |
Why?
|
| Kidney Medulla | 2 | 1993 | 182 | 0.030 |
Why?
|
| Suture Techniques | 1 | 2000 | 798 | 0.030 |
Why?
|
| Vagina | 1 | 2000 | 825 | 0.030 |
Why?
|
| Alcoholism | 1 | 2006 | 1906 | 0.030 |
Why?
|
| Testosterone | 1 | 2006 | 2420 | 0.030 |
Why?
|
| Neuromuscular Diseases | 3 | 1986 | 248 | 0.030 |
Why?
|
| Disease Models, Animal | 2 | 2012 | 18029 | 0.030 |
Why?
|
| Age Factors | 6 | 2012 | 18370 | 0.030 |
Why?
|
| Lipomatosis | 1 | 1975 | 112 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2008 | 12026 | 0.030 |
Why?
|
| Sarcolemma | 1 | 1993 | 66 | 0.030 |
Why?
|
| Necrosis | 1 | 1998 | 1643 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 1998 | 824 | 0.030 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 1993 | 494 | 0.030 |
Why?
|
| Reference Values | 3 | 1996 | 4982 | 0.030 |
Why?
|
| Muscular Diseases | 1 | 1977 | 556 | 0.030 |
Why?
|
| Emphysema | 1 | 1996 | 247 | 0.030 |
Why?
|
| Intercellular Junctions | 1 | 1993 | 203 | 0.030 |
Why?
|
| Television | 1 | 1996 | 409 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2012 | 158 | 0.030 |
Why?
|
| Rats, Inbred SHR | 1 | 2012 | 195 | 0.030 |
Why?
|
| Kidney Tubules, Collecting | 1 | 1993 | 178 | 0.030 |
Why?
|
| Phenylephrine | 2 | 2007 | 301 | 0.030 |
Why?
|
| Carcinoid Tumor | 1 | 1974 | 235 | 0.030 |
Why?
|
| Electric Stimulation Therapy | 1 | 1998 | 605 | 0.030 |
Why?
|
| Linear Models | 2 | 2007 | 5952 | 0.030 |
Why?
|
| Collagen | 2 | 1998 | 2689 | 0.030 |
Why?
|
| Fluorometry | 1 | 2011 | 106 | 0.030 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1975 | 340 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2012 | 23403 | 0.020 |
Why?
|
| Video Recording | 1 | 1996 | 949 | 0.020 |
Why?
|
| Lipid Peroxidation | 1 | 2011 | 270 | 0.020 |
Why?
|
| Radiography | 6 | 1985 | 7023 | 0.020 |
Why?
|
| Follow-Up Studies | 5 | 2003 | 39050 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1973 | 424 | 0.020 |
Why?
|
| Kidney Function Tests | 1 | 2012 | 684 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 1998 | 6365 | 0.020 |
Why?
|
| Transducers | 3 | 1976 | 252 | 0.020 |
Why?
|
| Forecasting | 1 | 1998 | 2951 | 0.020 |
Why?
|
| Acute Disease | 1 | 2000 | 7149 | 0.020 |
Why?
|
| Time Factors | 5 | 1998 | 40075 | 0.020 |
Why?
|
| Urography | 3 | 1981 | 313 | 0.020 |
Why?
|
| Blood Pressure | 2 | 2009 | 8554 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 1996 | 1359 | 0.020 |
Why?
|
| Erectile Dysfunction | 3 | 1995 | 461 | 0.020 |
Why?
|
| Losartan | 2 | 2003 | 299 | 0.020 |
Why?
|
| Dilatation | 3 | 1974 | 291 | 0.020 |
Why?
|
| Nitric Oxide | 1 | 1997 | 2132 | 0.020 |
Why?
|
| Prevalence | 4 | 2001 | 15226 | 0.020 |
Why?
|
| Survival Rate | 1 | 2003 | 12788 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2376 | 0.020 |
Why?
|
| Receptor, Nerve Growth Factor | 1 | 2007 | 48 | 0.020 |
Why?
|
| ROC Curve | 1 | 1995 | 3527 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 1974 | 804 | 0.020 |
Why?
|
| Adenocarcinoma | 2 | 2003 | 6364 | 0.020 |
Why?
|
| Latex | 1 | 2007 | 52 | 0.020 |
Why?
|
| Sodium | 1 | 1993 | 1623 | 0.020 |
Why?
|
| Reflex, Abnormal | 1 | 1987 | 84 | 0.020 |
Why?
|
| beta-Cyclodextrins | 1 | 2007 | 64 | 0.020 |
Why?
|
| Catalase | 1 | 2007 | 222 | 0.020 |
Why?
|
| Cholinergic Agonists | 1 | 2007 | 74 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2007 | 237 | 0.020 |
Why?
|
| Gene Expression | 2 | 2012 | 7799 | 0.020 |
Why?
|
| Bradykinin | 1 | 2007 | 214 | 0.020 |
Why?
|
| Carbachol | 1 | 2007 | 226 | 0.020 |
Why?
|
| Endoscopes | 1 | 1987 | 175 | 0.020 |
Why?
|
| Rest | 1 | 1991 | 901 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2007 | 149 | 0.020 |
Why?
|
| Lysosomes | 1 | 2011 | 893 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 1144 | 0.020 |
Why?
|
| Adrenergic alpha-Antagonists | 1 | 1985 | 174 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 2009 | 1423 | 0.020 |
Why?
|
| Anesthesia, Local | 1 | 1987 | 275 | 0.020 |
Why?
|
| Hypogastric Plexus | 1 | 1984 | 10 | 0.020 |
Why?
|
| Kidney Diseases | 2 | 1993 | 2149 | 0.020 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 1985 | 177 | 0.020 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 1979 | 427 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 2429 | 0.020 |
Why?
|
| Electrodiagnosis | 1 | 1984 | 151 | 0.010 |
Why?
|
| Antioxidants | 1 | 2011 | 1663 | 0.010 |
Why?
|
| Vasoconstrictor Agents | 1 | 2007 | 642 | 0.010 |
Why?
|
| Models, Anatomic | 1 | 2007 | 691 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 11366 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 977 | 0.010 |
Why?
|
| Catheterization | 1 | 1988 | 1470 | 0.010 |
Why?
|
| Serotonin | 1 | 2007 | 1017 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 1990 | 1372 | 0.010 |
Why?
|
| Prostatic Neoplasms | 2 | 2003 | 11124 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 4931 | 0.010 |
Why?
|
| Meningomyelocele | 1 | 2003 | 165 | 0.010 |
Why?
|
| Myosins | 1 | 2003 | 409 | 0.010 |
Why?
|
| Clinical Protocols | 2 | 1997 | 1462 | 0.010 |
Why?
|
| Adolescent | 8 | 2003 | 85781 | 0.010 |
Why?
|
| Kinesics | 1 | 1979 | 13 | 0.010 |
Why?
|
| Algorithms | 4 | 2007 | 13881 | 0.010 |
Why?
|
| Postoperative Complications | 5 | 1984 | 15295 | 0.010 |
Why?
|
| Biopsy | 3 | 1997 | 6756 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2012 | 77449 | 0.010 |
Why?
|
| Autonomic Nervous System | 1 | 1984 | 671 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1993 | 5021 | 0.010 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2007 | 1222 | 0.010 |
Why?
|
| Stress, Mechanical | 1 | 2004 | 1686 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 1996 | 21746 | 0.010 |
Why?
|
| Risk Factors | 2 | 2003 | 72290 | 0.010 |
Why?
|
| Muscle Relaxation | 1 | 1977 | 142 | 0.010 |
Why?
|
| Bacteriuria | 1 | 1978 | 102 | 0.010 |
Why?
|
| Physicians | 1 | 1996 | 4567 | 0.010 |
Why?
|
| Pharmaceutic Aids | 1 | 1976 | 6 | 0.010 |
Why?
|
| Diazepam | 1 | 1978 | 205 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1997 | 255 | 0.010 |
Why?
|
| Sheep | 1 | 2000 | 1437 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1995 | 15540 | 0.010 |
Why?
|
| Bethanechol Compounds | 1 | 1976 | 10 | 0.010 |
Why?
|
| Citrates | 1 | 1976 | 131 | 0.010 |
Why?
|
| Percussion | 1 | 1976 | 18 | 0.010 |
Why?
|
| Anal Canal | 1 | 1979 | 376 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 1984 | 3616 | 0.010 |
Why?
|
| Penile Erection | 1 | 1995 | 97 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 4751 | 0.010 |
Why?
|
| Postoperative Period | 1 | 1981 | 1842 | 0.010 |
Why?
|
| Hemorrhage | 2 | 1978 | 3461 | 0.010 |
Why?
|
| Preoperative Care | 1 | 1984 | 2250 | 0.010 |
Why?
|
| Seasons | 1 | 2001 | 1493 | 0.010 |
Why?
|
| Fetal Diseases | 1 | 2000 | 903 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 1 | 1997 | 916 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1974 | 419 | 0.010 |
Why?
|
| Electronics, Medical | 1 | 1974 | 71 | 0.010 |
Why?
|
| Shock, Traumatic | 1 | 1973 | 22 | 0.010 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 1974 | 49 | 0.010 |
Why?
|
| Castration | 1 | 1974 | 159 | 0.010 |
Why?
|
| Stomach Ulcer | 1 | 1974 | 125 | 0.010 |
Why?
|
| Muscle Tonus | 1 | 1973 | 81 | 0.010 |
Why?
|
| Hydronephrosis | 1 | 1975 | 269 | 0.010 |
Why?
|
| Elastic Tissue | 1 | 1973 | 65 | 0.010 |
Why?
|
| Hernia | 1 | 1973 | 71 | 0.010 |
Why?
|
| Brain Diseases | 1 | 2003 | 1563 | 0.010 |
Why?
|
| Swine | 1 | 2003 | 5917 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1993 | 3748 | 0.010 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 1 | 1993 | 102 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1996 | 20129 | 0.010 |
Why?
|
| Bumetanide | 1 | 1993 | 95 | 0.010 |
Why?
|
| Ouabain | 1 | 1993 | 264 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1993 | 349 | 0.010 |
Why?
|
| Comorbidity | 2 | 1998 | 10388 | 0.010 |
Why?
|
| Kidney Pelvis | 1 | 1973 | 188 | 0.010 |
Why?
|
| Furosemide | 1 | 1993 | 167 | 0.010 |
Why?
|
| Rupture | 1 | 1973 | 433 | 0.010 |
Why?
|
| Models, Statistical | 1 | 2007 | 5102 | 0.010 |
Why?
|
| Hypertrophy | 1 | 1993 | 569 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1975 | 1185 | 0.010 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 1997 | 924 | 0.010 |
Why?
|
| Renal Artery | 1 | 1973 | 398 | 0.010 |
Why?
|
| Sodium Channels | 1 | 1993 | 349 | 0.010 |
Why?
|
| Child | 3 | 2003 | 77709 | 0.010 |
Why?
|
| Aneurysm | 1 | 1973 | 339 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1993 | 1682 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2001 | 2624 | 0.010 |
Why?
|
| NAD | 1 | 1993 | 593 | 0.010 |
Why?
|
| Intestinal Diseases | 1 | 1973 | 530 | 0.010 |
Why?
|
| Death | 1 | 1973 | 678 | 0.010 |
Why?
|
| Biological Transport | 1 | 1993 | 2118 | 0.010 |
Why?
|
| Massachusetts | 1 | 2001 | 8663 | 0.000 |
Why?
|
| United States | 1 | 1996 | 69872 | 0.000 |
Why?
|
| Intestine, Small | 1 | 1973 | 1241 | 0.000 |
Why?
|
| Homes for the Aged | 1 | 1989 | 260 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 3798 | 0.000 |
Why?
|
| Monitoring, Physiologic | 1 | 1974 | 1738 | 0.000 |
Why?
|
| Oxygen Consumption | 1 | 1993 | 1869 | 0.000 |
Why?
|
| Attitude to Health | 1 | 1995 | 2052 | 0.000 |
Why?
|
| Multiple Sclerosis | 1 | 1980 | 3079 | 0.000 |
Why?
|
| Hemodynamics | 1 | 1995 | 4199 | 0.000 |
Why?
|
| Kinetics | 1 | 1993 | 6473 | 0.000 |
Why?
|
| Computer Simulation | 1 | 1995 | 6196 | 0.000 |
Why?
|
| Incidence | 1 | 1998 | 20947 | 0.000 |
Why?
|
| Metaplasia | 1 | 1977 | 313 | 0.000 |
Why?
|
| Quality of Life | 1 | 1998 | 12804 | 0.000 |
Why?
|
| Therapeutic Irrigation | 1 | 1976 | 301 | 0.000 |
Why?
|
| Dementia | 1 | 1989 | 2518 | 0.000 |
Why?
|
| Skin Neoplasms | 1 | 1973 | 5686 | 0.000 |
Why?
|
| Tomography, X-Ray | 1 | 1973 | 61 | 0.000 |
Why?
|
| Neurologic Examination | 1 | 1974 | 930 | 0.000 |
Why?
|
| Testis | 1 | 1973 | 803 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1973 | 4851 | 0.000 |
Why?
|
| Kidney Neoplasms | 1 | 1973 | 4262 | 0.000 |
Why?
|
| Prognosis | 1 | 1973 | 29063 | 0.000 |
Why?
|